BRUKINSA vs CAVHANZA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated July 29, 2026·How we rate

Possible drug interaction. BRUKINSA and CAVHANZA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	BRUKINSA	CAVHANZA
Rating	New	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	ZANUBRUTINIB	NILOTINIB
Manufacturer	Beone Medicines USA	Flex Pharma
Dosage forms	Capsule, Tablet	Tablet, orally disintegrating
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	None	None
Treats	Mantle-Cell Lymphoma	Accelerated Phase Myeloid Leukemia, Chronic-Phase Myeloid Leukemia, Gastrointestinal Stromal Tumors

brukinsa cavhanza

Rating

New

Pharmacy pays

—

Type

Active ingredient

ZANUBRUTINIB

NILOTINIB

Manufacturer

Beone Medicines USA

Flex Pharma

Dosage forms

Capsule, Tablet

Tablet, orally disintegrating

Drug class

Kinase Inhibitor

Boxed warning

None

Treats

Mantle-Cell Lymphoma

Accelerated Phase Myeloid Leukemia, Chronic-Phase Myeloid Leukemia, Gastrointestinal Stromal Tumors

Frequently asked questions

What is the difference between Brukinsa and Cavhanza?

Brukinsa contains Zanubrutinib, while Cavhanza contains Nilotinib — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.